SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-023450
Filing Date
2022-01-31
Accepted
2022-01-31 16:51:34
Documents
7
Effectiveness Date
2022-01-31

Document Format Files

Seq Description Document Type Size
1 S-8 d292184ds8.htm S-8 82711
2 EX-5.1 d292184dex51.htm EX-5.1 5068
3 EX-23.1 d292184dex231.htm EX-23.1 1531
4 EX-99.1 d292184dex991.htm EX-99.1 299674
5 EX-99.3 d292184dex993.htm EX-99.3 206627
6 EX-FILING FEES d292184dexfilingfees.htm EX-FILING FEES 7416
7 GRAPHIC g292184ex5_1logo.jpg GRAPHIC 3716
  Complete submission text file 0001193125-22-023450.txt   609292
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262432 | Film No.: 22574675
SIC: 2834 Pharmaceutical Preparations